HESTERBIO.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (14 May 2024 @ 05:20):

Stats
Today's Volume	5 364.00
Average Volume	10 570.00
Market Cap	14.77B
EPS	INR0 ( 2024-05-10 )
Next earnings date	( INR0 ) 2024-08-05
Last Dividend	INR8.00 ( 2023-09-13 )
Next Dividend	INR0 ( N/A )
P/E	77.52
ATR14	INR1.826 (0.11%)

Volume Correlation

Long: 0.11 (neutral)

Short: 0.32 (neutral)

Signal:(49.755) Neutral

Hester Biosciences Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hester Biosciences Correlation - Currency/Commodity

0.01
( neutral )

-0.06
( neutral )

-0.08
( neutral )

-0.16
( neutral )

-0.43
( neutral )

0.12
( neutral )

Hester Biosciences Financials

Annual	2023
Revenue:	INR3.05B
Gross Profit:	INR1.27B (41.82 %)
EPS:	INR22.20

FY	2023
Revenue:	INR3.05B
Gross Profit:	INR1.27B (41.82 %)
EPS:	INR22.20

FY	2022
Revenue:	INR2.66B
Gross Profit:	INR1.89B (70.88 %)
EPS:	INR31.30

FY	2022
Revenue:	INR2.35B
Gross Profit:	INR1.66B (70.70 %)
EPS:	INR46.22

Financial Reports:

No articles found.

Hester Biosciences Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR10.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR8.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Hester Biosciences Dividend Information - Dividend Junior

Dividend Sustainability Score: 7.35 - good (73.53%) | Divividend Growth Potential Score: 4.22 - Stable (15.57%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR3.10	2015-09-10
Last Dividend	INR8.00	2023-09-13
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	14	--
Total Paid Out	INR68.10	--
Avg. Dividend % Per Year	0.31%	--
Score	2.5	--
Div. Sustainability Score	7.35
Div.Growth Potential Score	4.22
Div. Directional Score	5.79	--

Next Divdend (Est)
(2024-08-26)

INR8.28 Estimate 3.41 %

Dividend Stability

0.27 Very Poor

Dividend Score

2.50

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR10.00	0.65%
2019	INR7.00	0.60%
2020	INR6.60	0.46%
2021	INR10.00	0.59%
2022	INR10.00	0.40%
2023	INR8.00	0.45%
2024	INR0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TATACONSUM.NS	Dividend Knight	2023-05-19	Annually	26	0.60%
NIACL.NS	No Dividend Player	2023-09-07	Sporadic	7	0.44%
IMFA.NS	Dividend Junior	2023-07-21	Annually	15	1.75%
CHENNPETRO.NS	Dividend Knight	2023-08-04	Sporadic	23	4.19%
SANGHVIMOV.NS	Dividend Junior	2023-08-04	Sporadic	18	0.41%
LXCHEM.NS	Dividend Junior	2023-07-20	Annually	4	0.11%
GILLETTE.NS	Dividend Knight	2023-11-21	Semi-Annually	21	0.85%
ASALCBR.NS	Dividend Junior	2023-07-26	Annually	5	0.17%
TIPSINDLTD.NS	Dividend Knight	2023-08-03	Annually	17	0.03%
PDSL.NS	Dividend Junior	2023-07-24	Annually	4	1.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0620	1.500	8.76	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0285	1.200	9.05	10.00	[0 - 0.3]
returnOnEquityTTM	0.0655	1.500	-0.384	-0.575	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.03	0.800	4.86	3.88	[1 - 3]
quickRatioTTM	0.943	0.800	9.16	7.32	[0.8 - 2.5]
cashRatioTTM	0.145	1.500	-0.307	-0.461	[0.2 - 2]
debtRatioTTM	0.361	-1.500	3.98	-5.98	[0 - 0.6]
interestCoverageTTM	2.31	1.000	-0.255	-0.255	[3 - 30]
operatingCashFlowPerShareTTM	44.19	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	44.19	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.819	-1.500	6.72	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.620	1.000	3.00	3.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.150	1.000	9.00	9.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.157	1.000	-0.237	-0.237	[0.2 - 2]
assetTurnoverTTM	0.460	0.800	-0.268	-0.214	[0.5 - 2]
Total Score				7.35

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	77.45	1.000	2.28	0	[1 - 100]
returnOnEquityTTM	0.0655	2.50	-0.247	-0.575	[0.1 - 1.5]
freeCashFlowPerShareTTM	44.19	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.465	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	44.19	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.886	1.500	0.759	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.123	1.000	9.41	0	[0.1 - 0.5]
Total Score				4.22

Hester Biosciences

Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates in two segments, Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for diseases, such as newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, egg drop syndrome, reo, marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, avian encephalomyelitis, etc. It also offers vaccines for large animals comprising Goat Pox, Peste des Petits Ruminants, Brucellosis, Mastitis, Metritis, and various infectious diseases, as well as infections, reproductive disorders, theileriosis, parasitic diseases, etc. In addition, the company provides feed supplements, such as toxin binder, trace minerals, enzyme preparation, and bypass fat; disinfectants for farms and equipment, and water sanitizers; nutrition products consisting of mineral mixtures, fertility supplements, and growth tonics; and herbal products, including growth promoters, herbal replacers for choline chloride, stress relievers and immunity boosters, respiratory stimulants, liver tonics, wound healing preparations, uterine tonics, digestive tonics and anti-bloat solutions, ectoparasiticide preparations, anti-mastitis, and anti-prolapse preparations. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India.